Joint Formulary & PAD

Budesonide with formoterol (Fobumix Easyhaler) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Budesonide with formoterol (Fobumix Easyhaler)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
Keywords :
ICS/LABAs, ICS LABAs, Respiratory, inhaled corticosteroids
Brand Names Include :
Fobumix Easyhaler
Important Information :

Prescribe by BRAND.

Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
3

Other Indications

Below are listed other indications that Budesonide with formoterol (Fobumix Easyhaler) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).

Committee Recommendations (1)

The locally preferred ICS/LABA devices are as follows:

Low carbon:

  • Fostair Nexthaler (beclometasone / formoterol DPI)
  • Fobumix Easyhaler (budesonide / formoterol DPI)
  • Relvar Ellipta (Fluticasone / vilanterol DPI)
  • Symbicort Turbohaler (budesonide / formoterol DPI)

Alternative devices:

  • Fostair (beclometasone / formoterol MDI)
  • Symbicort (budesonide / formoterol MDI)

Devices should be prescribed by BRAND

A spacer device should be used with MDI devices.

See full COPD guidelines below